Bone Biologics Prices $5,100,000 Million Underwritten Public Offering

BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces the pricing of an underwritten public offering of 3,777,778 units of securities at an offering price of $1.35 per unit, for total gross proceeds of $5,100,000 million, before deducting underwriting discounts and commissions and other estimated offering expenses. … [Read more…]

Global Ophthalmology Devices Market to Grow by $17.09 Billion During 2022-2026 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmology Devices Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering. The ophthalmology devices market is poised to grow by $17.09 bn during 2022-2026, accelerating at a CAGR of 4.1% during the forecast period. The report on the ophthalmology devices market provides a holistic analysis, market size and forecast, trends, growth drivers, … [Read more…]

Bristol Myers Squibb Announces Change to Earnings Conference Call Dial-In Information for Third Quarter 2022 Results Scheduled for October 26, 2022

NEW YORK–(BUSINESS WIRE)–$BMY #BMS—Bristol Myers Squibb (NYSE:BMY) announced that it has changed the dial-in and replay information of its previously announced third quarter 2022 earnings conference call scheduled for Wednesday, October 26, 2022. Company executives will review financial results and address inquiries from investors and analysts during a conference call at 8:00 a.m. ET that … [Read more…]

Diabetic Eye Disease Devices Global Market to Grow by 7.64% Annually Through 2029 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Diabetic Eye Disease Devices Market Analysis, by Disease, by Devices, by End-User, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The diabetic eye disease devices market size is estimated to be USD 1305.1 million in 2021 and is expected to witness a CAGR of 7.64% during … [Read more…]

96% of Humana’s Medicare Advantage Members are in Contracts rated 4-Star or Above for 2023; 66% are in Contracts Rated 4.5-Star or Higher

Humana received a 5 out of 5-star rating for HMO plans in Louisiana, Tennessee and Kentucky, covering approximately 356,000 members Humana received a 4.5-star rating for Medicare Advantage contracts offered in 46 states and Puerto Rico, covering more than 3 million members, nearly double last year’s members in plans with this rating 4.9 million, or … [Read more…]

Saudi Arabia Foot & Ankle Devices Market Report 2022: Technological Advancements in Medical Devices Bolstering Sector Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Saudi Arabia Foot & Ankle Devices Market, By Product Type (Joint Implants, Fixation Devices, Soft Tissue Orthopedic Devices, Bracing & Support Devices, Prostheses), By Procedure, By Application, By End User, By Region, Competition Forecast & Opportunities, 2027” report has been added to ResearchAndMarkets.com’s offering. Saudi Arabia foot & ankle devices market is projected … [Read more…]

Elevance Health’s Affiliated 2023 Medicare Advantage Health Plans Earn High Quality Scores from CMS

Elevance Health’s affiliated Medicare Advantage plans achieved an overall 4 out of 5 Star rating. INDIANAPOLIS–(BUSINESS WIRE)–$Anthem #Anthem–Elevance Health, Inc. (NYSE: ELV) announced today that its 2023 affiliated Medicare Advantage plans have earned an overall quality rating of 4 out of 5 Stars from the Centers for Medicare & Medicaid Services (CMS). Many of Elevance … [Read more…]

Transdermal Drug Delivery Systems Global Market Report 2022: Growing Instances of Chronic Disorders That Cannot Be Treated Through Conventional Drug Delivery Systems Fueling Sector – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Transdermal Drug Delivery Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global transdermal drug delivery systems market size reached US$ 6.0 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 8.7 Billion by 2027, exhibiting a CAGR … [Read more…]

POC Hba1C Testing Global Market Report 2022: Skyrocketing Diabetes Rates Fueling Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “POC Hba1C Testing Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global POC HbA1C testing market is expected to grow from $1.53 billion in 2021 to $1.73 billion in 2022 at a compound annual growth rate (CAGR) of 13.2%. The POC HbA1C market is expected to grow to $2.43 … [Read more…]

Microbiome Therapeutics Global Market Report 2022: Rising Prevalence of Obesity Expected to Propel Sector Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Microbiome Therapeutics Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global microbiome therapeutics market is expected to grow from $0.29 billion in 2021 to $0.39 billion in 2022 at a compound annual growth rate (CAGR) of 34.7%. The microbiome therapeutics market is expected to grow to $1 billion in … [Read more…]